TAK Stock Ownership Activity

TAKEDA PHARMACEUTIC-SP ADR 13F holders

1 value investing guru has made changes to the TAKEDA PHARMACEUTIC-SP ADR (TAK) position according to the gurus' latest SEC quarterly report(s). The number of TAK shares has been increased by 1 super investor(s).

Which gurus or hedge funds are buying TAK now?

According to the latest SEC filing(s) TAKEDA PHARMACEUTIC-SP ADR (TAK) has been bought by Sarah Ketterer - Causeway Capital Management (added shares +7.38%).

To see more about who is investing in TAKEDA PHARMACEUTIC-SP ADR (TAK), please go to the TAK ownership page.

2024 Q1 (1 result)
Sarah Ketterer
+7.38%
+98,766
+0.04%
0.52%
Current price: $13.39 3.60% Reported price*: $13.89
2023 Q4 (1 result)
Sarah Ketterer
+8.14%
+101,336
+0.04%
0.49%
Current price: $13.39 6.17% Reported price*: $14.27
2023 Q3 (1 result)
Sarah Ketterer
+11.04%
+123,725
+0.05%
0.51%
Current price: $13.39 13.45% Reported price*: $15.47
2023 Q2 (1 result)
Sarah Ketterer
-0.78%
-8,782
-0.00%
0.46%
Current price: $13.39 14.77% Reported price*: $15.71
2023 Q1 (1 result)
Sarah Ketterer
-15.09%
-200,676
-0.08%
0.45%
Current price: $13.39 18.75% Reported price*: $16.48
2022 Q4 (1 result)
Sarah Ketterer
-7.04%
-100,663
-0.05%
0.60%
Current price: $13.39 14.17% Reported price*: $15.60
2022 Q3 (1 result)
Sarah Ketterer
-5.05%
-70,789
-0.03%
0.48%
Current price: $13.39 3.24% Reported price*: $12.97
2022 Q2 (1 result)
Sarah Ketterer
-5.89%
-89,982
-0.03%
0.50%
Current price: $13.39 4.63% Reported price*: $14.04
2022 Q1 (1 result)
Sarah Ketterer
+6.09%
+91,897
+0.03%
0.55%
Current price: $13.39 6.49% Reported price*: $14.32
2021 Q4 (1 result)
Sarah Ketterer
-20.86%
-280,483
-0.12%
0.32%
Current price: $13.39 1.76% Reported price*: $13.63
2021 Q3 (1 result)
Sarah Ketterer
-6.12%
-77,666
-0.05%
0.44%
Current price: $13.39 18.25% Reported price*: $16.38
2021 Q2 (1 result)
Sarah Ketterer
+21.38%
+184,271
+0.12%
0.36%
Current price: $13.39 20.44% Reported price*: $16.83
2021 Q1 (1 result)
Sarah Ketterer
+8.37%
+129,284
+0.05%
0.60%
Current price: $13.39 26.67% Reported price*: $18.26
2020 Q4 (1 result)
Sarah Ketterer
+4.44%
+54,158
+0.02%
0.44%
Current price: $13.39 26.43% Reported price*: $18.20
2020 Q3 (1 result)
Sarah Ketterer
-4.02%
-61,855
-0.02%
0.49%
Current price: $13.39 24.94% Reported price*: $17.84
2020 Q2 (1 result)
Sarah Ketterer
-29.12%
-392,451
-0.20%
0.31%
Current price: $13.39 25.32% Reported price*: $17.93
2020 Q1 (1 result)
Sarah Ketterer
-13.15%
-328,931
-0.08%
0.53%
Current price: $13.39 11.79% Reported price*: $15.18
2019 Q4 (2 results)
Sarah Ketterer
-1.04%
-26,204
-0.01%
0.53%
Seth Klarman
-100.00%
-9,434,803
-1.89%
0.00%
Current price: $13.39 32.13% AVG reported price*: $19.73
2019 Q3 (2 results)
Seth Klarman
-0.03%
-3,200
-0.00%
0.00%
Sarah Ketterer
-0.76%
-17,797
-0.00%
0.48%
Current price: $13.39 22.15% AVG reported price*: $17.20
2019 Q2 (2 results)
Sarah Ketterer
+6.67%
+159,387
+0.03%
0.49%
Seth Klarman
-11.54%
-1,058,675
-0.20%
1.34%
Current price: $13.39 24.35% AVG reported price*: $17.70
2019 Q1 (2 results)
Seth Klarman
buy
+10,669,021
+1.88%
1.88%
Sarah Ketterer
+8.35%
+183,969
+0.04%
0.49%
Current price: $13.39 34.27% AVG reported price*: $20.37
2018 Q4 (1 result)
Sarah Ketterer
buy
+2,204,384
+0.44%
0.44%
Current price: $13.39 20.39% Reported price*: $16.82
26 of 26

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.